Clinical Trial: Cytokine Changes After Colorectal Cancer Resection

A look at the following clinical trial: Cytokine Changes After Colorectal Cancer Resection

Clinical Trial: Sentinel Concept in Early Stage Cervical Cancer

A look at the following clinical trial: Sentinel Concept in Early Stage Cervical Cancer

Clinical Trial: Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer or Polyposis Syndrome or Who Are at High Risk of Developing Hereditary Colorectal Cancer

A look at the following clinical trial: Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer or Polyposis Syndrome or Who Are at High Risk of Developing Hereditary Colorectal Cancer

Clinical Trial: Trial of Aspirin and Arginine Restriction in Colorectal Cancer

A look at the following clinical trial: Trial of Aspirin and Arginine Restriction in Colorectal Cancer

Clinical Trial: Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print

A look at the following clinical trial: Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print

Clinical Trial: Colorectal Cancer Screening in Average-Risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy

A look at the following clinical trial: Colorectal Cancer Screening in Average-Risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy

Clinical Trial: MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)

A look at the following clinical trial: MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)

Clinical Trials: Study of Pegfilgrastim Administered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab and Either FOLFOX or FOLFIRI

Provides information to potential participants on the following clinical trial: Study of Pegfilgrastim Administered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab and Either FOLFOX or FOLFIRI

Clinical Trials: A Phase I/II Study of Gleevec® Combined With Panitumumab (Vectibix®) in Patients Prescreened for C-kit/PDGFr Activated Pathways Using a Proteomic Based Assay

Provides information to potential participants on the following clinical trial: A Phase I/II Study of Gleevec® Combined With Panitumumab (Vectibix®) in Patients Prescreened for C-kit/PDGFr Activated Pathways Using a Proteomic Based Assay

Clinical Trials: A Randomized, Multicenter, Phase 2 Study to Compare the Efficacy of Panitumumab in Combination With mFOLFOX6 to the Efficacy of Bevacizumab in Combination With mFOLFOX6 in Patients With Previously Untreated, KRAS Wild-Type, Unresectable, M

Provides information to potential participants on the following clinical trial: A Randomized, Multicenter, Phase 2 Study to Compare the Efficacy of Panitumumab in Combination With mFOLFOX6 to the Efficacy of Bevacizumab in Combination With mFOLFOX6 in Patients With Previously Untreated, KRAS Wild-Type, Unresectable, Metastatic Colorectal Cancer

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs